All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.


Protocadherin Beta 2 as a Promising Prognostic and Immunotherapeutic Predictive Indicator in Gastric Cancer

Author(s): X. Liu, Yuzhu Tang, H. Luo, J. Fan, Tian Li, H. Li and Z. Fan*
Department of Pharmacy, Graduate School, Hebei North University, Qiaodong, Zhangjiakou 075000, 1Department of Oncology, Air Force Medical Center, Air Force Medical University, Haidian, Beijing 100142, 2Second School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510330, 3School of Basic Medicine, Fourth Military Medical University, Xi’an, Shaanxi 710032, China

Correspondence Address:
Z. Fan, Department of Oncology, Air Force Medical Center, Air Force Medical University, Haidian, Beijing 100142, China, E-mail:

Protocadherin beta 2 belongs to the procalcitonin family and is implicated in the progression of various tumors. It is linked to unfavorable prognosis in patients suffering from different types of cancers, whereas limited investigation was conducted on protocadherin beta 2 in gastric cancer. This study identified the key genes involved in tumor microenvironment of gastric cancer, ultimately pinpointing protocadherin beta 2 as the main focus of investigation. Analysis of survival data in the Cancer Genome Atlas and Gene Expression Omnibus databases indicated that patients with gastric cancer who exhibited elevated levels of protocadherin beta 2 had higher likelihood of experiencing unfavorable survival outcomes. Furthermore, the expression of protocadherin beta 2 demonstrated a strong association with tumor staging and grading. Gene set enrichment analysis indicated that protocadherin beta 2 was primarily linked to cell adhesion molecules, transforming growth factor-beta signaling pathway, phosphoinositide-3-kinase-protein kinase B signaling pathway and antigen-antibody presentation. Analysis of immune infiltration revealed a robust association between the expression of protocadherin beta 2 and infiltration of immune cells into tumors, which was found to be significant in relation to immune checkpoint inhibitors, leukocyte antigens; negatively correlated with microsatellite instability index, tumor mutation burden index and tumor immune dysfunction and exclusion scores. The analysis of drug prediction indicated that increased expression of protocadherin beta 2 exhibited greater responsiveness to anticancer medications like gemcitabine, 5-fluorouracil and adriamycin. Examining the prognostic and immunotherapeutic significance of protocadherin beta 2 in gastric cancer, this investigation reveals that protocadherin beta 2 influences the tumor microenvironment and prognosis of gastric cancer.

Full-Text | PDF

Google scholar citation report
Citations : 66710

Indian Journal of Pharmaceutical Sciences received 66710 citations as per google scholar report